Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248737 · ClinicalTrials.gov registry record
Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken
A clinical trial of Nutrition, Healthy, sponsored by Cornell University.
- Active
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT05248737: Active study of Nutrition, Healthy, sponsored by Cornell University.
NCT05248737 is a study of Nutrition, Healthy that is active but no longer recruiting, run by Cornell University. The registered enrollment target is 84 participants, below the 152-participant average among 31 other Nutrition, Healthy trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05248737, a study of Nutrition, Healthy, is active but no longer recruiting, sponsored by Cornell University.
- ACTIVE NOT RECRUITING
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.
Primary Outcome
Measuring plasma DHA concentration across different time points to assess DHA bioavailability and absorption
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT DHA/EPA fortified chicken plus Placebo
- DIETARY_SUPPLEMENT non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement
- DIETARY_SUPPLEMENT non-DHA bio-enhanced chicken plus supplement DHA Omega-3
- DIETARY_SUPPLEMENT 25(OH)D bioenhanced chicken and eggs plus placebo
- DIETARY_SUPPLEMENT Dietary Supplement: DHA/EPA fortified eggs plus Placebo
Study Locations (1)
New York
- Human Metabolic Research Unit - Ithaca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-12-04 |
| Est. Completion | 2026-01-30 |
What the registry record for NCT05248737 still lists
NCT05248737 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 152-participant average among 31 other Nutrition, Healthy trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Nutrition, Healthy appearing as the primary indexed condition, and to 5 interventions - of which DHA/EPA fortified chicken plus Placebo is the first listed.
NCT05248737 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05248737 about?
NCT05248737 is a clinical study titled "Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken". The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this...
What is the current status of trial NCT05248737?
This trial is currently active not recruiting. The enrollment target is 84 participants. The study started on 2021-12-04. Estimated completion is 2026-01-30.
What conditions does trial NCT05248737 study?
This clinical trial studies the following conditions: Nutrition, Healthy.
What interventions are being tested in trial NCT05248737?
The interventions under investigation include: DHA/EPA fortified chicken plus Placebo (DIETARY_SUPPLEMENT), non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement (DIETARY_SUPPLEMENT), non-DHA bio-enhanced chicken plus supplement DHA Omega-3 (DIETARY_SUPPLEMENT), 25(OH)D bioenhanced chicken and eggs plus placebo (DIETARY_SUPPLEMENT), Dietary Supplement: DHA/EPA fortified eggs plus Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05248737?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05248737 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nutrition, Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05248737's enrollment target sits among peer trials
84 15th of 31 higher than 16 of 31 other Nutrition, Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nutrition, Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
Food FARMacia: Reducing Childhood Obesity in Households With Food Insecurity
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI